Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells

Transplantation

Volumn 83, Issue 11, 2007, Pages 1449-1458

  Grazia, Todd J ^a   Plenter, Robert J ^b,c   Doan, An N ^b,c   Kelly, Brian P ^b,c   Weber, Sarah M ^b   Kurche, Jonathan S ^b   Cushing, Susan O ^b   Gill, Ronald G ^b   Pietra, Biagio A ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c CHILDREN S HOSPITAL   (United States)

Author keywords

B7 1; B7 2; CD80; CD86; Costimulation; Linked suppression; Tolerance; Transplantation

Indexed keywords

ANTIBODY; B7 ANTIGEN; CD25 ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADOPTIVE TRANSFER; ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CELL TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T CELL DEPLETION; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HOMEODOMAIN PROTEINS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; SPLEEN; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 34250656523     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000265482.88936.b1     Document Type: Article

References (40)

1. Freeman GJ, Freedman AS, Segil JM, et al. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989; 143: 2714.
2. Freeman GJ, Gribben JG, Boussiotis VA, et al. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T-cell proliferation. Science 1993; 262: 909.
3. Azuma M, Ito D, Yagita H, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76.
4. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A 1992; 89: 11102.
5. Bluestone JA. Costimulation and its role in organ transplantation. Clin Transplant 1996; 10: 104.
6. Liang B, Gee RJ, Kashgarian MJ, et al. B7 costimulation in the development of lupus: Autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. J Immunol 1999; 163: 2322.
7. Bagenstose LM, Class R, Salgame P, Monestier M. B7-1 and B7-2 costimulatory molecules are required for mercury-induced autoimmunity. Clin Exp Immunol 2002; 127: 12.
8. Linsley PS, Greene JL, Tan P, et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 1992; 176: 1595.
9. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992; 257: 789.
10. Walunas TL, Bluestone JA. CTLA-4 regulates tolerance induction and T-cell differentiation in vivo. J Immunol 1998; 160: 3855.
11. Van Ginderachter JA, Liu Y, Geldhof AB, et al. B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma. Int J Cancer 2000; 87: 539.
12. Boussiotis VA, Freeman GJ, Gray G, et al. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993; 178: 1753.
13. Onodera K, Chandraker A, Schaub M, et al. CD28-B7 T-cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: Induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. J Immunol 1997; 159: 1711.
14. Mandelbrot DA, Furukawa Y, McAdam AJ, et al. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol 1999; 163: 3753.
15. Szot GL, Zhou P, Sharpe AH, et al. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation 2000; 69: 904.
16. Pietra BA, Wiseman A, Bolwerk A, et al. CD4 T-cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000; 106: 1003.
17. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50: 366.
18. Onodera K, Lehmann M, Akalin E, et al. Induction of " infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996; 157: 1944.
19. Pearson TC, Hamano K, Morris PJ, Wood KJ. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. Transplant Proc 1993; 25: 786.
20. Pearson TC, Darby CR, Wood KJ. Successful secondary heterotopic cardiac transplantation in the mouse. Transplantation 1992; 53: 701.
21. Orosz CG, Wakely E, Bergese SD, et al. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Transplantation 1996; 61: 783.
22. Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
23. Grazia TJ, Pietra BA, Johnson ZA, et al. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol 2004; 172: 7451.
24. Mandelbrot DA, Kishimoto K, Auchincloss H, Jr., et al. Rejection of mouse cardiac allografts by costimulation in trans. J Immunol 2001; 167: 1174.
25. Ding L, Shevach EM. Activation of CD4+ T-cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (transcostimulation). Eur J Immunol 1994; 24: 859.
26. Ferlazzo G, Semino C, Meta M, et al. T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties. Eur J Immunol 2002; 32: 3092.
27. Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T-cells that control autoimmune diabetes. Immunity 2000; 12: 431.
28. Tang Q, Henriksen KJ, Boden EK, et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T-cells. J Immunol 2003; 171: 3348.
29. Liang S, Alard P, Zhao Y, et al. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T-cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005; 201: 127.
30. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T-cell differentiation independently of interleukin 2. Nat Immunol 2005; 6: 152.
31. Bour-Jordan H, Salomon BL, Thompson HL, et al. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T-cells. J Clin Invest 2004; 114: 979.
32. Borriello F, Sethna MP, Boyd SD, et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997; 6: 303.
33. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
34. Davies JD, Leong LY, Mellor A, et al. T-cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602.
35. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T-cells in dominant self-tolerance and autoimmune disease. Immunological Rev 2006; 212: 8.
36. Jiang S, Lechler RI, He XS, Huang JF. CD4+CD25+ regulatory T-cell therapy for the induction of donor-specific clinical transplantation tolerance. Exp Opin Biol Therapy 2006; 6: 1003.
37. Nicolls MR, Coulombe M, Yang H, et al. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. J Immunol 2000; 164: 3627.
38. Nicolls MR, Coulombe M, Beilke J, et al. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J Immunol 2002; 169: 4831.
39. Nishimura E, Sakihama T, Setoguchi R, et al. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T-cells. Int Immunol 2004; 16: 1189.
40. Domenig C, Sanchez-Fueyo A, Kurtz J, et al. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. J Immunol 2005; 175: 51.